> top > docs > PubMed:3921386 > annotations

PubMed:3921386 JSONTXT

Annnotations TAB JSON ListView MergeView

spacy-test

Id Subject Object Predicate Lexical cue
spaCy_T0 0-11 JJ denotes Arachidonic
spaCy_T1 12-24 JJ denotes acid-induced
spaCy_T2 25-33 NN denotes platelet
spaCy_T3 34-45 NN denotes aggregation
spaCy_T4 46-49 CC denotes and
spaCy_T5 50-60 JJ denotes prostanoid
spaCy_T6 61-70 NN denotes formation
spaCy_T7 71-73 IN denotes in
spaCy_T8 74-79 JJ denotes whole
spaCy_T9 80-85 NN denotes blood
spaCy_T10 86-88 IN denotes in
spaCy_T11 89-97 NN denotes relation
spaCy_T12 98-100 TO denotes to
spaCy_T13 101-107 NN denotes plasma
spaCy_T14 108-121 NN denotes concentration
spaCy_T15 122-124 IN denotes of
spaCy_T16 125-137 NN denotes indomethacin
spaCy_T17 137-138 . denotes .
spaCy_T18 139-140 DT denotes A
spaCy_T19 141-147 JJ denotes single
spaCy_T20 148-152 JJ denotes oral
spaCy_T21 153-157 NN denotes dose
spaCy_T22 158-160 IN denotes of
spaCy_T23 161-173 NN denotes indomethacin
spaCy_T24 174-175 CD denotes 1
spaCy_T25 176-181 NN denotes mg/kg
spaCy_T26 182-185 VBD denotes was
spaCy_T27 186-191 VBN denotes given
spaCy_T28 192-194 TO denotes to
spaCy_T29 195-196 CD denotes 6
spaCy_T30 197-201 NN denotes male
spaCy_T31 202-205 CC denotes and
spaCy_T32 206-207 CD denotes 6
spaCy_T33 208-214 JJ denotes female
spaCy_T34 215-225 NNS denotes volunteers
spaCy_T35 225-226 . denotes .
spaCy_T36 227-230 DT denotes The
spaCy_T37 231-240 NN denotes formation
spaCy_T38 241-243 IN denotes of
spaCy_T39 244-255 NN denotes thromboxane
spaCy_T40 256-258 NN denotes B2
spaCy_T41 259-260 -LRB- denotes (
spaCy_T42 260-264 CD denotes TXB2
spaCy_T43 264-265 -RRB- denotes )
spaCy_T44 266-269 CC denotes and
spaCy_T45 270-290 JJ denotes 6-keto-prostaglandin
spaCy_T46 291-293 CD denotes F1
spaCy_T47 294-299 NN denotes alpha
spaCy_T48 300-301 -LRB- denotes (
spaCy_T49 301-312 JJ denotes 6-keto-PGF1
spaCy_T50 313-318 NN denotes alpha
spaCy_T51 318-319 -RRB- denotes )
spaCy_T52 320-322 IN denotes in
spaCy_T53 323-331 VBG denotes clotting
spaCy_T54 332-337 JJ denotes whole
spaCy_T55 338-343 NN denotes blood
spaCy_T56 344-347 VBD denotes was
spaCy_T57 348-356 VBN denotes measured
spaCy_T58 357-359 IN denotes by
spaCy_T59 360-376 NN denotes radioimmunoassay
spaCy_T60 376-377 , denotes ,
spaCy_T61 378-381 CC denotes and
spaCy_T62 382-390 NN denotes platelet
spaCy_T63 391-402 NN denotes aggregation
spaCy_T64 403-410 VBN denotes induced
spaCy_T65 411-413 IN denotes by
spaCy_T66 414-425 JJ denotes arachidonic
spaCy_T67 426-430 NN denotes acid
spaCy_T68 431-432 -LRB- denotes (
spaCy_T69 432-434 NNP denotes AA
spaCy_T70 434-435 -RRB- denotes )
spaCy_T71 436-439 VBD denotes was
spaCy_T72 440-448 VBN denotes measured
spaCy_T73 449-453 IN denotes with
spaCy_T74 454-455 DT denotes a
spaCy_T75 456-462 NN denotes plasma
spaCy_T76 463-475 NN denotes aggregometer
spaCy_T77 475-476 . denotes .
spaCy_T78 477-480 DT denotes The
spaCy_T79 481-488 NNS denotes results
spaCy_T80 489-493 VBD denotes were
spaCy_T81 494-501 VBN denotes related
spaCy_T82 502-504 TO denotes to
spaCy_T83 505-508 DT denotes the
spaCy_T84 509-520 JJ denotes concomitant
spaCy_T85 521-527 NN denotes plasma
spaCy_T86 528-541 NN denotes concentration
spaCy_T87 542-544 IN denotes of
spaCy_T88 545-557 NN denotes indomethacin
spaCy_T89 557-558 . denotes .
spaCy_T90 559-562 DT denotes The
spaCy_T91 563-570 NN denotes maximum
spaCy_T92 571-577 NN denotes plasma
spaCy_T93 578-591 NN denotes concentration
spaCy_T94 592-598 VBD denotes ranged
spaCy_T95 599-606 IN denotes between
spaCy_T96 607-611 CD denotes 3.24
spaCy_T97 612-615 CC denotes and
spaCy_T98 616-620 CD denotes 8.11
spaCy_T99 621-634 NN denotes micrograms/ml
spaCy_T100 635-638 CC denotes and
spaCy_T101 639-642 DT denotes the
spaCy_T102 643-654 NN denotes elimination
spaCy_T103 655-664 NN denotes half-life
spaCy_T104 665-672 IN denotes between
spaCy_T105 673-674 CD denotes 4
spaCy_T106 675-678 CC denotes and
spaCy_T107 679-681 CD denotes 11
spaCy_T108 682-684 NN denotes h.
spaCy_T109 685-694 NN denotes Formation
spaCy_T110 695-697 IN denotes of
spaCy_T111 698-701 DT denotes the
spaCy_T112 702-713 NNS denotes prostanoids
spaCy_T113 714-717 VBD denotes was
spaCy_T114 718-728 RB denotes reversibly
spaCy_T115 729-738 VBN denotes inhibited
spaCy_T116 738-739 , denotes ,
spaCy_T117 740-744 IN denotes with
spaCy_T118 745-752 NN denotes maximum
spaCy_T119 753-764 NN denotes suppression
spaCy_T120 765-769 WRB denotes when
spaCy_T121 770-773 DT denotes the
spaCy_T122 774-778 NN denotes drug
spaCy_T123 779-792 NN denotes concentration
spaCy_T124 793-795 IN denotes in
spaCy_T125 796-802 NN denotes plasma
spaCy_T126 803-811 VBD denotes exceeded
spaCy_T127 812-817 CD denotes 0.5-1
spaCy_T128 817-819 CD denotes .0
spaCy_T129 820-832 NN denotes microgram/ml
spaCy_T130 832-833 : denotes ;
spaCy_T131 834-837 DT denotes the
spaCy_T132 838-842 NNP denotes IC50
spaCy_T133 843-846 VBD denotes was
spaCy_T134 847-860 RB denotes approximately
spaCy_T135 861-864 CD denotes 0.1
spaCy_T136 865-877 NN denotes microgram/ml
spaCy_T137 877-878 . denotes .
spaCy_T138 879-887 NNP denotes Platelet
spaCy_T139 888-899 NN denotes aggregation
spaCy_T140 900-903 VBD denotes was
spaCy_T141 904-908 RB denotes also
spaCy_T142 909-919 RB denotes reversibly
spaCy_T143 920-929 VBN denotes inhibited
spaCy_T144 929-930 . denotes .
spaCy_T145 931-934 DT denotes The
spaCy_T146 935-946 NN denotes correlation
spaCy_T147 947-954 IN denotes between
spaCy_T148 955-958 DT denotes the
spaCy_T149 959-968 NN denotes formation
spaCy_T150 969-971 IN denotes of
spaCy_T151 972-983 NNS denotes prostanoids
spaCy_T152 984-987 CC denotes and
spaCy_T153 988-991 DT denotes the
spaCy_T154 992-1001 JJ denotes different
spaCy_T155 1002-1008 NNS denotes phases
spaCy_T156 1009-1011 IN denotes of
spaCy_T157 1012-1015 DT denotes the
spaCy_T158 1016-1027 JJ denotes aggregatory
spaCy_T159 1028-1036 NN denotes response
spaCy_T160 1037-1039 TO denotes to
spaCy_T161 1040-1049 JJ denotes exogenous
spaCy_T162 1050-1052 NNP denotes AA
spaCy_T163 1053-1055 VBZ denotes is
spaCy_T164 1056-1065 VBN denotes discussed
spaCy_T165 1065-1066 . denotes .
spaCy_R0 spaCy_T0 spaCy_T3 amod Arachidonic,aggregation
spaCy_R1 spaCy_T1 spaCy_T3 amod acid-induced,aggregation
spaCy_R2 spaCy_T2 spaCy_T3 compound platelet,aggregation
spaCy_R3 spaCy_T3 spaCy_T3 ROOT aggregation,aggregation
spaCy_R4 spaCy_T4 spaCy_T3 cc and,aggregation
spaCy_R5 spaCy_T5 spaCy_T6 amod prostanoid,formation
spaCy_R6 spaCy_T6 spaCy_T3 conj formation,aggregation
spaCy_R7 spaCy_T7 spaCy_T6 prep in,formation
spaCy_R8 spaCy_T8 spaCy_T9 amod whole,blood
spaCy_R9 spaCy_T9 spaCy_T7 pobj blood,in
spaCy_R10 spaCy_T10 spaCy_T6 prep in,formation
spaCy_R11 spaCy_T11 spaCy_T10 pobj relation,in
spaCy_R12 spaCy_T12 spaCy_T11 prep to,relation
spaCy_R13 spaCy_T13 spaCy_T14 compound plasma,concentration
spaCy_R14 spaCy_T14 spaCy_T12 pobj concentration,to
spaCy_R15 spaCy_T15 spaCy_T14 prep of,concentration
spaCy_R16 spaCy_T16 spaCy_T15 pobj indomethacin,of
spaCy_R17 spaCy_T17 spaCy_T3 punct .,aggregation
spaCy_R18 spaCy_T18 spaCy_T21 det A,dose
spaCy_R19 spaCy_T19 spaCy_T21 amod single,dose
spaCy_R20 spaCy_T20 spaCy_T21 amod oral,dose
spaCy_R21 spaCy_T21 spaCy_T27 nsubjpass dose,given
spaCy_R22 spaCy_T22 spaCy_T21 prep of,dose
spaCy_R23 spaCy_T23 spaCy_T25 nmod indomethacin,mg/kg
spaCy_R24 spaCy_T24 spaCy_T23 nummod 1,indomethacin
spaCy_R25 spaCy_T25 spaCy_T22 pobj mg/kg,of
spaCy_R26 spaCy_T26 spaCy_T27 auxpass was,given
spaCy_R27 spaCy_T27 spaCy_T27 ROOT given,given
spaCy_R28 spaCy_T28 spaCy_T27 prep to,given
spaCy_R29 spaCy_T29 spaCy_T34 nummod 6,volunteers
spaCy_R30 spaCy_T30 spaCy_T34 amod male,volunteers
spaCy_R31 spaCy_T31 spaCy_T30 cc and,male
spaCy_R32 spaCy_T32 spaCy_T34 nummod 6,volunteers
spaCy_R33 spaCy_T33 spaCy_T34 amod female,volunteers
spaCy_R34 spaCy_T34 spaCy_T28 pobj volunteers,to
spaCy_R35 spaCy_T35 spaCy_T27 punct .,given
spaCy_R36 spaCy_T36 spaCy_T37 det The,formation
spaCy_R37 spaCy_T37 spaCy_T57 nsubjpass formation,measured
spaCy_R38 spaCy_T38 spaCy_T37 prep of,formation
spaCy_R39 spaCy_T39 spaCy_T40 compound thromboxane,B2
spaCy_R40 spaCy_T40 spaCy_T38 pobj B2,of
spaCy_R41 spaCy_T41 spaCy_T40 punct (,B2
spaCy_R42 spaCy_T42 spaCy_T40 appos TXB2,B2
spaCy_R43 spaCy_T43 spaCy_T40 punct ),B2
spaCy_R44 spaCy_T44 spaCy_T37 cc and,formation
spaCy_R45 spaCy_T45 spaCy_T47 amod 6-keto-prostaglandin,alpha
spaCy_R46 spaCy_T46 spaCy_T47 nummod F1,alpha
spaCy_R47 spaCy_T47 spaCy_T37 conj alpha,formation
spaCy_R48 spaCy_T48 spaCy_T50 punct (,alpha
spaCy_R49 spaCy_T49 spaCy_T50 amod 6-keto-PGF1,alpha
spaCy_R50 spaCy_T50 spaCy_T47 appos alpha,alpha
spaCy_R51 spaCy_T51 spaCy_T50 punct ),alpha
spaCy_R52 spaCy_T52 spaCy_T37 prep in,formation
spaCy_R53 spaCy_T53 spaCy_T52 pcomp clotting,in
spaCy_R54 spaCy_T54 spaCy_T55 amod whole,blood
spaCy_R55 spaCy_T55 spaCy_T53 dobj blood,clotting
spaCy_R56 spaCy_T56 spaCy_T57 auxpass was,measured
spaCy_R57 spaCy_T57 spaCy_T57 ROOT measured,measured
spaCy_R58 spaCy_T58 spaCy_T57 agent by,measured
spaCy_R59 spaCy_T59 spaCy_T58 pobj radioimmunoassay,by
spaCy_R60 spaCy_T60 spaCy_T57 punct ",",measured
spaCy_R61 spaCy_T61 spaCy_T57 cc and,measured
spaCy_R62 spaCy_T62 spaCy_T63 compound platelet,aggregation
spaCy_R63 spaCy_T63 spaCy_T72 nsubjpass aggregation,measured
spaCy_R64 spaCy_T64 spaCy_T63 acl induced,aggregation
spaCy_R65 spaCy_T65 spaCy_T64 agent by,induced
spaCy_R66 spaCy_T66 spaCy_T67 amod arachidonic,acid
spaCy_R67 spaCy_T67 spaCy_T65 pobj acid,by
spaCy_R68 spaCy_T68 spaCy_T67 punct (,acid
spaCy_R69 spaCy_T69 spaCy_T67 appos AA,acid
spaCy_R70 spaCy_T70 spaCy_T67 punct ),acid
spaCy_R71 spaCy_T71 spaCy_T72 auxpass was,measured
spaCy_R72 spaCy_T72 spaCy_T57 conj measured,measured
spaCy_R73 spaCy_T73 spaCy_T72 prep with,measured
spaCy_R74 spaCy_T74 spaCy_T76 det a,aggregometer
spaCy_R75 spaCy_T75 spaCy_T76 compound plasma,aggregometer
spaCy_R76 spaCy_T76 spaCy_T73 pobj aggregometer,with
spaCy_R77 spaCy_T77 spaCy_T72 punct .,measured
spaCy_R78 spaCy_T78 spaCy_T79 det The,results
spaCy_R79 spaCy_T79 spaCy_T81 nsubjpass results,related
spaCy_R80 spaCy_T80 spaCy_T81 auxpass were,related
spaCy_R81 spaCy_T81 spaCy_T81 ROOT related,related
spaCy_R82 spaCy_T82 spaCy_T81 prep to,related
spaCy_R83 spaCy_T83 spaCy_T86 det the,concentration
spaCy_R84 spaCy_T84 spaCy_T86 amod concomitant,concentration
spaCy_R85 spaCy_T85 spaCy_T86 compound plasma,concentration
spaCy_R86 spaCy_T86 spaCy_T82 pobj concentration,to
spaCy_R87 spaCy_T87 spaCy_T86 prep of,concentration
spaCy_R88 spaCy_T88 spaCy_T87 pobj indomethacin,of
spaCy_R89 spaCy_T89 spaCy_T81 punct .,related
spaCy_R90 spaCy_T90 spaCy_T93 det The,concentration
spaCy_R91 spaCy_T91 spaCy_T93 amod maximum,concentration
spaCy_R92 spaCy_T92 spaCy_T93 compound plasma,concentration
spaCy_R93 spaCy_T93 spaCy_T94 nsubj concentration,ranged
spaCy_R94 spaCy_T94 spaCy_T133 ccomp ranged,was
spaCy_R95 spaCy_T95 spaCy_T94 prep between,ranged
spaCy_R96 spaCy_T96 spaCy_T95 pobj 3.24,between
spaCy_R97 spaCy_T97 spaCy_T96 cc and,3.24
spaCy_R98 spaCy_T98 spaCy_T96 conj 8.11,3.24
spaCy_R99 spaCy_T99 spaCy_T96 conj micrograms/ml,3.24
spaCy_R100 spaCy_T100 spaCy_T99 cc and,micrograms/ml
spaCy_R101 spaCy_T101 spaCy_T103 det the,half-life
spaCy_R102 spaCy_T102 spaCy_T103 compound elimination,half-life
spaCy_R103 spaCy_T103 spaCy_T115 nsubjpass half-life,inhibited
spaCy_R104 spaCy_T104 spaCy_T103 prep between,half-life
spaCy_R105 spaCy_T105 spaCy_T104 pobj 4,between
spaCy_R106 spaCy_T106 spaCy_T105 cc and,4
spaCy_R107 spaCy_T107 spaCy_T105 conj 11,4
spaCy_R108 spaCy_T108 spaCy_T109 compound h.,Formation
spaCy_R109 spaCy_T109 spaCy_T105 conj Formation,4
spaCy_R110 spaCy_T110 spaCy_T109 prep of,Formation
spaCy_R111 spaCy_T111 spaCy_T112 det the,prostanoids
spaCy_R112 spaCy_T112 spaCy_T110 pobj prostanoids,of
spaCy_R113 spaCy_T113 spaCy_T115 auxpass was,inhibited
spaCy_R114 spaCy_T114 spaCy_T115 advmod reversibly,inhibited
spaCy_R115 spaCy_T115 spaCy_T99 conj inhibited,micrograms/ml
spaCy_R116 spaCy_T116 spaCy_T115 punct ",",inhibited
spaCy_R117 spaCy_T117 spaCy_T115 prep with,inhibited
spaCy_R118 spaCy_T118 spaCy_T119 amod maximum,suppression
spaCy_R119 spaCy_T119 spaCy_T117 pobj suppression,with
spaCy_R120 spaCy_T120 spaCy_T126 advmod when,exceeded
spaCy_R121 spaCy_T121 spaCy_T123 det the,concentration
spaCy_R122 spaCy_T122 spaCy_T123 compound drug,concentration
spaCy_R123 spaCy_T123 spaCy_T126 nsubj concentration,exceeded
spaCy_R124 spaCy_T124 spaCy_T123 prep in,concentration
spaCy_R125 spaCy_T125 spaCy_T124 pobj plasma,in
spaCy_R126 spaCy_T126 spaCy_T115 advcl exceeded,inhibited
spaCy_R127 spaCy_T127 spaCy_T129 nummod 0.5-1,microgram/ml
spaCy_R128 spaCy_T128 spaCy_T129 nummod .0,microgram/ml
spaCy_R129 spaCy_T129 spaCy_T126 dobj microgram/ml,exceeded
spaCy_R130 spaCy_T130 spaCy_T133 punct ;,was
spaCy_R131 spaCy_T131 spaCy_T132 det the,IC50
spaCy_R132 spaCy_T132 spaCy_T133 nsubj IC50,was
spaCy_R133 spaCy_T133 spaCy_T133 ROOT was,was
spaCy_R134 spaCy_T134 spaCy_T135 advmod approximately,0.1
spaCy_R135 spaCy_T135 spaCy_T136 nummod 0.1,microgram/ml
spaCy_R136 spaCy_T136 spaCy_T133 attr microgram/ml,was
spaCy_R137 spaCy_T137 spaCy_T133 punct .,was
spaCy_R138 spaCy_T138 spaCy_T139 compound Platelet,aggregation
spaCy_R139 spaCy_T139 spaCy_T140 nsubj aggregation,was
spaCy_R140 spaCy_T140 spaCy_T143 auxpass was,inhibited
spaCy_R141 spaCy_T141 spaCy_T143 advmod also,inhibited
spaCy_R142 spaCy_T142 spaCy_T143 advmod reversibly,inhibited
spaCy_R143 spaCy_T143 spaCy_T143 ROOT inhibited,inhibited
spaCy_R144 spaCy_T144 spaCy_T143 punct .,inhibited
spaCy_R145 spaCy_T145 spaCy_T146 det The,correlation
spaCy_R146 spaCy_T146 spaCy_T164 nsubjpass correlation,discussed
spaCy_R147 spaCy_T147 spaCy_T146 prep between,correlation
spaCy_R148 spaCy_T148 spaCy_T149 det the,formation
spaCy_R149 spaCy_T149 spaCy_T147 pobj formation,between
spaCy_R150 spaCy_T150 spaCy_T149 prep of,formation
spaCy_R151 spaCy_T151 spaCy_T150 pobj prostanoids,of
spaCy_R152 spaCy_T152 spaCy_T151 cc and,prostanoids
spaCy_R153 spaCy_T153 spaCy_T155 det the,phases
spaCy_R154 spaCy_T154 spaCy_T155 amod different,phases
spaCy_R155 spaCy_T155 spaCy_T151 conj phases,prostanoids
spaCy_R156 spaCy_T156 spaCy_T155 prep of,phases
spaCy_R157 spaCy_T157 spaCy_T159 det the,response
spaCy_R158 spaCy_T158 spaCy_T159 amod aggregatory,response
spaCy_R159 spaCy_T159 spaCy_T156 pobj response,of
spaCy_R160 spaCy_T160 spaCy_T159 prep to,response
spaCy_R161 spaCy_T161 spaCy_T162 amod exogenous,AA
spaCy_R162 spaCy_T162 spaCy_T160 pobj AA,to
spaCy_R163 spaCy_T163 spaCy_T164 auxpass is,discussed
spaCy_R164 spaCy_T164 spaCy_T164 ROOT discussed,discussed
spaCy_R165 spaCy_T165 spaCy_T164 punct .,discussed

oger-json-test

Id Subject Object Predicate Lexical cue
T1 0-16 D016718 denotes Arachidonic acid
T2 0-16 CHEBI:15843 denotes Arachidonic acid
T3 12-16 CHEBI:37527 denotes acid
T4 25-33 CL:0000233 denotes platelet
T5 25-45 GO:0070527 denotes platelet aggregation
T6 50-60 CHEBI:26347 denotes prostanoid
T7 50-70 GO:0046457 denotes prostanoid formation
T8 61-70 GO:0009058 denotes formation
T9 125-137 D007213 denotes indomethacin
T10 125-137 CHEBI:49662 denotes indomethacin
T11 141-147 SO:0000984 denotes single
T12 161-173 D007213 denotes indomethacin
T13 161-173 CHEBI:49662 denotes indomethacin
T14 197-201 CHEBI:30780 denotes male
T15 202-207 CVCL_CX63 denotes and 6
T16 231-240 GO:0009058 denotes formation
T17 244-255 CHEBI:26995 denotes thromboxane
T18 244-258 D013929 denotes thromboxane B2
T19 244-258 CHEBI:90696 denotes thromboxane B2
T20 244-258 CHEBI:28728 denotes thromboxane B2
T21 260-263 CHEBI:26996 denotes TXB
T22 260-264 CHEBI:28728 denotes TXB2
T23 266-271 CVCL_CX63 denotes and 6
T24 270-299 CHEBI:28158 denotes 6-keto-prostaglandin F1 alpha
T25 277-290 CHEBI:26333 denotes prostaglandin
T26 277-293 C100006 denotes prostaglandin F1
T27 277-293 CHEBI:28852 denotes prostaglandin F1
T28 277-299 C100006 denotes prostaglandin F1 alpha
T29 277-299 CHEBI:28852 denotes prostaglandin F1 alpha
T30 277-299 CHEBI:133421 denotes prostaglandin F1 alpha
T31 294-299 CHEBI:30216 denotes alpha
T32 294-312 D015121 denotes alpha (6-keto-PGF1
T33 301-318 D015121 denotes 6-keto-PGF1 alpha
T34 301-318 CHEBI:28158 denotes 6-keto-PGF1 alpha
T35 308-311 CVCL_E806 denotes PGF
T36 308-311 PR:000012605 denotes PGF
T37 308-311 D011460 denotes PGF
T38 308-311 CHEBI:26340 denotes PGF
T39 308-312 C100006 denotes PGF1
T40 308-312 P05980 denotes PGF1
T41 308-318 C100006 denotes PGF1 alpha
T42 308-318 CHEBI:28852 denotes PGF1 alpha
T43 313-318 CHEBI:30216 denotes alpha
T44 323-331 GO:0050817 denotes clotting
T45 382-390 CL:0000233 denotes platelet
T46 382-402 GO:0070527 denotes platelet aggregation
T47 414-430 D016718 denotes arachidonic acid
T48 414-430 CHEBI:15843 denotes arachidonic acid
T49 426-430 CHEBI:37527 denotes acid
T50 545-557 D007213 denotes indomethacin
T51 545-557 CHEBI:49662 denotes indomethacin
T52 702-713 CHEBI:26347 denotes prostanoids
T53 702-713 D011453 denotes prostanoids
T54 774-778 CHEBI:23888 denotes drug
T55 879-887 CL:0000233 denotes Platelet
T56 879-899 GO:0070527 denotes Platelet aggregation
T57 959-968 GO:0009058 denotes formation
T58 972-983 CHEBI:26347 denotes prostanoids
T59 972-983 D011453 denotes prostanoids